User Image Cart Icon 0 Search Image

Dyslipidemia Obesity

  1. OBESITY and DYSLIPIDEMIA: a review of current evidence
  2. OBESITY and DYSLIPIDEMIA
  3. OBESITY and DYSLIPIDEMIA
  4. DYSLIPIDEMIA in OBESITY: mechanisms and potential targets
  5. OBESITY and DYSLIPIDEMIA
  6. OBESITY and DYSLIPIDEMIA
  7. OBESITY and DYSLIPIDEMIA
  8. Risk of DYSLIPIDEMIA in obese young adult subjects as measured by various OBESITY indices
  9. Tackling DYSLIPIDEMIA in OBESITY from a nanotechnology perspective
  10. Lipid profile and the frequency of DYSLIPIDEMIA in Iranian adolescents with severe OBESITY, who were candidates for bariatric surgery
  11. Consumption of Green Tea As Anti-DYSLIPIDEMIA Agent and OBESITY Prevention: A Systematic Review
  12. Lifestyle Intervention in Reducing Cardiometabolic Risk Factors in Students with DYSLIPIDEMIA and Abdominal OBESITY: A Randomized Study
  13. DYSLIPIDEMIA and pediatric OBESITY
  14. DYSLIPIDEMIA, OBESITY, and ethnicity in Mexican children
  15. OBESITY and DYSLIPIDEMIA in early life: Impact on cardiometabolic risk
  16. OBESITY and DYSLIPIDEMIA in South Asians
  17. OBESITY and DYSLIPIDEMIA in Chinese adults: a cross-sectional study in Shanghai, China
  18. DYSLIPIDEMIA and abdominal OBESITY: an assessment in three general populations
  19. OBESITY and atherogenic DYSLIPIDEMIA
  20. Association of OBESITY with hypertension and DYSLIPIDEMIA in type 2 diabetes mellitus subjects
  21. Associations of OBESITY and DYSLIPIDEMIA with intake of sodium, fat, and sugar among Koreans: a qualitative systematic review
  22. DYSLIPIDEMIA, OBESITY and other cardiovascular risk factors in the adult population in Senegal
  23. DYSLIPIDEMIA of central OBESITY and insulin resistance
  24. OBESITY and DYSLIPIDEMIA.
  25. The association of DYSLIPIDEMIA and OBESITY with glycated hemoglobin
  26. OBESITY, adiposity, and DYSLIPIDEMIA: a consensus statement from the National Lipid Association
  27. A Holistic View of Psoriasis: Examining Its Association With DYSLIPIDEMIA and OBESITY in a Decade-Long Systematic Review and Meta-Analysis
  28. The effects of antioxidants from natural products on OBESITY, DYSLIPIDEMIA, diabetes and their molecular signaling mechanism
  29. OBESITY, hypertension, and DYSLIPIDEMIA in childhood are key modifiable antecedents of adult cardiovascular disease: a call to action
  30. DYSLIPIDEMIA in visceral OBESITY: mechanisms, implications, and therapy
  31. Association of anthropometric variables with DYSLIPIDEMIA in OBESITY
  32. OBESITY and its metabolic complications: the role of adipokines and the relationship between OBESITY, inflammation, insulin resistance, DYSLIPIDEMIA and …
  33. Association of general and abdominal OBESITY with hypertension, DYSLIPIDEMIA and prediabetes in the PREDAPS Study
  34. Approach to identifying and managing atherogenic DYSLIPIDEMIA: a metabolic consequence of OBESITY and diabetes
  35. Prevalence of OBESITY, high blood pressure, DYSLIPIDEMIA and their associated factors in children and adolescents in a municipality in the Brazilian Amazon …
  36. OBESITY and risk for its comorbidities diabetes, hypertension, and DYSLIPIDEMIA in Japanese individuals aged 65 years
  37. The impact of stress systems and lifestyle on DYSLIPIDEMIA and OBESITY in anxiety and depression
  38. Effects of vitamin D supplementation on fasting glucose, DYSLIPIDEMIA, blood pressure, and abdominal OBESITY among patients with metabolic syndrome: a …
  39. Association of central type of OBESITY and hypertension in patients with DYSLIPIDEMIA
  40. OBESITY, DYSLIPIDEMIA, and high blood pressure are associated with cardiovascular risk, determined using high-sensitivity C-reactive protein concentration, in young …
  41. DYSLIPIDEMIA Incidents Between General OBESITY and Central OBESITY of Employees with OBESITY at Universitas Lampung
  42. Insulin resistance: a multifaceted syndrome responsible for NIDDM, OBESITY, hypertension, DYSLIPIDEMIA, and atherosclerotic cardiovascular disease
  43. Drugs involved in DYSLIPIDEMIA and OBESITY treatment: focus on adipose tissue
  44. The prevalence of overweight/OBESITY and DYSLIPIDEMIA amongst a group of women attending “August” meeting
  45. Association of hypertension, diabetes, DYSLIPIDEMIA, and metabolic syndrome with OBESITY: findings from the National Health and Nutrition Examination Survey, 1999 …
  46. Evidence in obese children: contribution of tri-ponderal mass index or body mass index to DYSLIPIDEMIA, OBESITY-inflammation, and insulin sensitivity
  47. Prevalence of DYSLIPIDEMIA and OBESITY among college students in Kuwait
  48. OBESITY, Hypertension, and DYSLIPIDEMIA 11
  49. The relationship between OBESITY and DYSLIPIDEMIA in adolescents
  50. High prevalence of OBESITY in rheumatoid arthritis patients: association with disease activity, hypertension, DYSLIPIDEMIA and diabetes, a multi-center study
  51. OBESITY in DYSLIPIDEMIA and hypertension: A study among young adults of Delhi/NCR
  52. The interplay of OBESITY, DYSLIPIDEMIA and immune dysfunction: a brief overview on pathophysiology, animal models, and nutritional modulation
  53. Functional foods against metabolic syndrome (OBESITY, diabetes, hypertension and DYSLIPIDEMIA) and cardiovasular disease
  54. Prospects of potential adipokines as therapeutic agents in OBESITY-linked atherogenic DYSLIPIDEMIA and insulin resistance
  55. Impact of diabetes, OBESITY, and DYSLIPIDEMIA on the risk of hepatocellular carcinoma in patients with chronic liver diseases
  56. Effect of OBESITY, DYSLIPIDEMIA, and diabetes on trastuzumab-related cardiotoxicity in breast cancer
  57. Association of OBESITY indexes with hypertension and DYSLIPIDEMIA in Chinese adults
  58. Longitudinal relationship of depressive and anxiety symptoms with DYSLIPIDEMIA and abdominal OBESITY
  59. Increased hepatic CD36 expression contributes to DYSLIPIDEMIA associated with diet-induced OBESITY
  60. DYSLIPIDEMIA and cardiovascular risk in OBESITY
  61. … and its constituents against cardiovascular risk factors including OBESITY, hypertension, atherosclerosis, diabetes, and DYSLIPIDEMIA: A comprehensive review
  62. Maternal OBESITY and DYSLIPIDEMIA associated with gestational diabetes mellitus (GDM)
  63. The synergistic effect of OBESITY and DYSLIPIDEMIA on hypertension: results from the STEPS survey
  64. DYSLIPIDEMIA-a-meta-analysis.pdf”>The Cross Talk Between Psoriasis, OBESITY, and DYSLIPIDEMIA: A Meta-Analysis
  65. Body mass index is better than other anthropometric indices for identifying DYSLIPIDEMIA in Chinese children with OBESITY
  66. OBESITY and DYSLIPIDEMIA as Risk Factors of Vascular Cognitive Impairment in Adult Hypertensive Nigerian
  67. Increased oxidative stress in OBESITY: implications for metabolic syndrome, diabetes, hypertension, DYSLIPIDEMIA, atherosclerosis, and cancer
  68. Comparison of various abdominal OBESITY measures for predicting metabolic syndrome, diabetes, nephropathy, and DYSLIPIDEMIA
  69. DYSLIPIDEMIA and maternal OBESITY: Prematurity and neonatal prognosis
  70. Comorbid overweight/OBESITY and chronic pancreatitis exacerbate the DYSLIPIDEMIA progression in type 2 diabetic patients
  71. DYSLIPIDEMIA.pdf”>A review of COVID-19 in relation to metabolic syndrome: OBESITY, hypertension, diabetes, and DYSLIPIDEMIA
  72. Reduced HDL particle size as an additional feature of the atherogenic DYSLIPIDEMIA of abdominal OBESITY
  73. Causal association of OBESITY and DYSLIPIDEMIA with type 2 diabetes: a two-sample mendelian randomization study
  74. OBESITY and DYSLIPIDEMIA: risk factors for development of senile cataract
  75. Obstructive sleep apnea and cardiovascular risk: the role of DYSLIPIDEMIA, inflammation, and OBESITY
  76. Association of perinatal factors with severe OBESITY and DYSLIPIDEMIA in adulthood
  77. Plasma vitamin D and parathormone are associated with OBESITY and atherogenic DYSLIPIDEMIA: a cross-sectional study
  78. Hepatic lipase and DYSLIPIDEMIA: interactions among genetic variants, OBESITY, gender, and diet
  79. Waist circumference as a preventive tool of atherogenic DYSLIPIDEMIA and OBESITY-associated cardiovascular risk in young adults males: a cross-sectional pilot …
  80. Abdominal OBESITY and DYSLIPIDEMIA in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk
  81. OBESITY-Status-Linked Affecting Factors of DYSLIPIDEMIA in Korean Young-Adult Men: Based on the Korea National Health and Nutrition Examination Survey …
  82. Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of OBESITY and DYSLIPIDEMIA using a potent and selective small molecule inhibitor
  83. The Longitudinal Effect of Ultra‐Processed Food on the Development of DYSLIPIDEMIA/OBESITY as Assessed by the NOVA System and Food Compass Score
  84. Effect of OBESITY and Associated Disorders like Diabetes, DYSLIPIDEMIA & Hypertension on Levels of Serum Complement Component C3 in Indian Ethnic …
  85. OBESITY and DYSLIPIDEMIA–An urgent matter in youth from the general population and in type 1 diabetic patients
  86. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, OBESITY, and DYSLIPIDEMIA
  87. Diabetic DYSLIPIDEMIA and association of glycemic status with lipid profile, body mass index and abdominal OBESITY
  88. OBESITY, DYSLIPIDEMIA, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study.
  89. Classification and prediction on the effects of nutritional intake on overweight/OBESITY, DYSLIPIDEMIA, hypertension and type 2 diabetes mellitus using deep …
  90. Effect of piperine in the regulation of OBESITY-induced DYSLIPIDEMIA in high-fat diet rats
  91. Single strain probiotics for DYSLIPIDEMIA, fatty liver, and OBESITY: A systematic review and meta-analysis
  92. Bacterial endotoxin activity in human serum is associated with DYSLIPIDEMIA, insulin resistance, OBESITY, and chronic inflammation
  93. Interaction between adipocytes and high-density lipoprotein: new insights into the mechanism of OBESITY-induced DYSLIPIDEMIA and atherosclerosis
  94. Implications of serum paraoxonase activity in OBESITY, diabetes mellitus, and DYSLIPIDEMIA
  95. Association between subclinical hypothyroidism and DYSLIPIDEMIA in the OBESITY population
  96. Clustering of DYSLIPIDEMIA, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall OBESITY in a general population
  97. COMBINED EFFECTS OF OBESITY AND SMOKING ON DYSLIPIDEMIA IN ADULTS WITH HYPERTENSION BY GENDER
  98. Low dose organochlorine pesticides and polychlorinated biphenyls predict OBESITY, DYSLIPIDEMIA, and insulin resistance among people free of diabetes
  99. Prevalence of overweight/OBESITY and its associations with hypertension, diabetes, DYSLIPIDEMIA, and metabolic syndrome: a survey in the suburban area of Beijing …
  100. OBESITY, DYSLIPIDEMIA and brain age in first-episode psychosis
  101. OBESITY, DYSLIPIDEMIA and other Risks Factors for Metabolic Syndrome among Indigenous Black African Secondary School Students in Lagos, Nigeria
  102. DYSLIPIDEMIA, alcohol consumption, and OBESITY as main factors associated with poor control of urate levels in patients receiving urate‐lowering therapy
  103. Self-Efficacy, Physical Function, and Healthy Behaviors in a Working Adult Population Living with OBESITY and DYSLIPIDEMIA, Hypertension, or Diabetes Mellitus
  104. OBESITY and DYSLIPIDEMIA synergistically exacerbate psoriatic skin inflammation
  105. Correlation Between Life Style and DYSLIPIDEMIA of Teacher Secondary School with Central OBESITY in Makassar City 2016
  106. The prevalence of hypertension, OBESITY and DYSLIPIDEMIA in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang
  107. Visceral OBESITY, hepatic lipase activity, and DYSLIPIDEMIA in type 1 diabetes
  108. Association of OBESITY and insulin resistance with DYSLIPIDEMIA in Indian women with polycystic ovarian syndrome.
  109. DYSLIPIDEMIA_among.16.aspx”>OBESITY, hypertension, and DYSLIPIDEMIA among human immunodeficiency virus patients in Abeokuta Ogun State, Nigeria
  110. Exposure to perfluoroalkyl substances (PFAS) and DYSLIPIDEMIA, hypertension and OBESITY in adolescents. The Fit Futures study
  111. Screening of DYSLIPIDEMIA and OBESITY among Children in Zagazig University Hospitals
  112. High prevalence of OBESITY, DYSLIPIDEMIA and metabolic syndrome in a rural area in Pakistan
  113. Changing relationships of OBESITY and DYSLIPIDEMIA in Greek children: 1982–2002
  114. Central OBESITY and atherogenic DYSLIPIDEMIA in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
  115. DYSLIPIDEMIA, OBESITY and coronavirus disease 2019 (COVID-19)
  116. Osteosarcopenic OBESITY and its relationship with DYSLIPIDEMIA in women from different ethnic groups of China
  117. OBESITY and DYSLIPIDEMIA among Bhil tribal population: A cross-sectional study from India
  118. Hyperinsulinemia, DYSLIPIDEMIA, and OBESITY as risk factors for hospitalized gallbladder disease: a prospective study
  119. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive DYSLIPIDEMIA with sexually dimorphic OBESITY and steatosis
  120. Correlation between sarcopenic OBESITY and DYSLIPIDEMIA in the young and middle aged adults
  121. Effects of oil tea on OBESITY and DYSLIPIDEMIA: A cross-sectional study in China
  122. Diabetes prevalence is associated with OBESITY, hypertension, DYSLIPIDEMIA, and sociodemographic factors in adults living in Casablanca-Settat and Rabat-Sale …
  123. The Cross Talk Between Psoriasis, OBESITY, and DYSLIPIDEMIA: A Meta-Analysis
  124. DYSLIPIDEMIA AND OBESITY AS RISK FACTORS IN CARDIAC ARRHYTHMIAS DIAGNOSED BY HOLTER MONITORING ECG OR STANDARD ECG.
  125. Studies of gene variants related to inflammation, oxidative stress, DYSLIPIDEMIA, and OBESITY: implications for a nutrigenetic approach
  126. Metabolic and metabo-clinical signatures of type 2 diabetes, OBESITY, retinopathy, and DYSLIPIDEMIA
  127. In and out: adipose tissue lipid turnover in OBESITY and DYSLIPIDEMIA
  128. Exposure to light at night, nocturnal urinary melatonin excretion, and OBESITY/DYSLIPIDEMIA in the elderly: a cross-sectional analysis of the HEIJO-KYO study
  129. DYSLIPIDEMIA and meibomian gland dysfunction: utility of lipidomics and experimental prospects with a diet-induced OBESITY mouse model
  130. Postprandial DYSLIPIDEMIA in men with visceral OBESITY: an effect of reduced LDL receptor expression?
  131. A study on effect of yoga and various asanas on OBESITY, hypertension and DYSLIPIDEMIA
  132. The role of gut microbiota and its produced metabolites in OBESITY, DYSLIPIDEMIA, adipocyte dysfunction, and its interventions
  133. Association of DYSLIPIDEMIA, hypertension and overweight/OBESITY with work shift and duration of employment among police officers in a small town in …
  134. A Study on Comparision of Methods for Predicting OBESITY and DYSLIPIDEMIA
  135. Serum apolipoprotein B predicts DYSLIPIDEMIA, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central OBESITY and …
  136. Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with OBESITY and DYSLIPIDEMIA in young subjects
  137. Serum thyrotropin is positively correlated with the metabolic syndrome components of OBESITY and DYSLIPIDEMIA in chinese adolescents
  138. Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central OBESITY, and DYSLIPIDEMIA
  139. Preventive and ameliorating effects of citrus D-limonene on DYSLIPIDEMIA and hyperglycemia in mice with high-fat diet-induced OBESITY
  140. The associations of total and differential white blood cell counts with OBESITY, hypertension, DYSLIPIDEMIA and glucose intolerance in a Korean population
  141. Effect of ShanZha, a Chinese herbal product, on OBESITY and DYSLIPIDEMIA in hamsters receiving high-fat diet
  142. Differences in the management of hypertension, diabetes mellitus and DYSLIPIDEMIA between OBESITY classes
  143. Challenges in the pharmacologic management of OBESITY and secondary DYSLIPIDEMIA in children and adolescents
  144. Prevalence of overweight, OBESITY and DYSLIPIDEMIA in health workers at the primary level.
  145. The Effects of OBESITY and Physical Activity on DYSLIPIDEMIA in Persons With Type 2 Diabetes
  146. The association of leptin with DYSLIPIDEMIA, arterial hypertension and OBESITY in Kyrgyz (Central Asian nation) population
  147. Sarcopenia and sarcopenic OBESITY and their association with DYSLIPIDEMIA in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination …
  148. Evaluation of alterations in serum immunoglobulin concentrations in components of metabolic syndrome, OBESITY, diabetes, and DYSLIPIDEMIA
  149. The Association of Peptide Hormones with Glycemia, DYSLIPIDEMIA, and OBESITY in Lebanese Individuals
  150. Prevalence of overweight/OBESITY and its association with diabetes, hypertension, DYSLIPIDEMIA and metabolic syndrome: a cross-sectional study of a sample of …
  151. Red mold rice prevents the development of OBESITY, DYSLIPIDEMIA and hyperinsulinemia induced by high-fat diet
  152. Cardiovascular risk factors in polycystic ovary syndrome; the relationship of DYSLIPIDEMIA and OBESITY
  153. Association between OBESITY and therapeutic goal attainment in patients with concomitant hypertension and DYSLIPIDEMIA
  154. Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of OBESITY, insulin resistance, DYSLIPIDEMIA, and hepatic steatosis
  155. High prevalence of overweight/OBESITY and DYSLIPIDEMIA in patients with intracranial germ cell tumors
  156. FACTORS AFFECTING PREVALENCE OF OBESITY AND ITS ASSOCIATION WITH DYSLIPIDEMIA AMONG SCHOOL CHILDREN IN LUDHIANA
  157. DYSLIPIDEMIA without OBESITY in indigenous Argentinean children living at high altitude
  158. Growth hormone overexpression in the central nervous system results in hyperphagia-induced OBESITY associated with insulin resistance and DYSLIPIDEMIA
  159. Nuclear receptors as drug targets in OBESITY, DYSLIPIDEMIA and atherosclerosis.
  160. DYSLIPIDEMIA links OBESITY to early cerebral neurochemical alterations
  161. Comparison of different OBESITY indicators with DYSLIPIDEMIA and hypertension in adults of Guangxi Yao ethnic group
  162. Association between OBESITY and DYSLIPIDEMIA among rural primary and middle school students in Students Nutrition Improvement Program Areas of Zhejiang …
  163. Assessment of OBESITY, DYSLIPIDEMIA, Hyperglycemia, and Pro-Inflammatory Cytokines as Cardiovascular Disease Risk Factors in Acromegaly Patients
  164. Intestinal PPARδ protects against diet-induced OBESITY, insulin resistance and DYSLIPIDEMIA
  165. Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with OBESITY and DYSLIPIDEMIA
  166. To examine the relationship between OBESITY-related DYSLIPIDEMIA and anthropometric indicators
  167. Higher hepcidin levels in adolescents with OBESITY are associated with metabolic syndrome DYSLIPIDEMIA and visceral fat
  168. Linkage analysis of quantitative traits for OBESITY, diabetes, hypertension, and DYSLIPIDEMIA on the island of Kosrae, Federated States of Micronesia
  169. Prevalence of DYSLIPIDEMIA in non-obese prepubertal children and its association with family history of diabetes, high blood pressure, and OBESITY
  170. Impact of vitamin D deficiency, DYSLIPIDEMIA and OBESITY on serum lipidomic profile. Search for new biomarkers as early predictors of OBESITY-associated comorbidities.
  171. Bovine growth hormone transgenic mice are resistant to diet-induced OBESITY but develop hyperphagia, DYSLIPIDEMIA, and diabetes on a high-fat diet
  172. The association between early-life famine exposure and adulthood OBESITY on the risk of DYSLIPIDEMIA
  173. … with inflammation, oxidative stress, impaired glucose metabolism, and DYSLIPIDEMIA in the crosstalk between childhood OBESITY and insulin resistance
  174. Reprogrammed functional brown adipocytes ameliorate insulin resistance and DYSLIPIDEMIA in diet-induced OBESITY and type 2 diabetes
  175. Effect of Soybean and Soybean Koji on OBESITY and DYSLIPIDEMIA in Rats Fed a High-Fat Diet: A Comparative Study
  176. OBESITY and DYSLIPIDEMIA in patients with psoriasis treated at a dermatologic clinic in Manaus
  177. Bile acid control of metabolism and inflammation in OBESITY, type 2 diabetes, DYSLIPIDEMIA, and nonalcoholic fatty liver disease
  178. Association of inflammation, DYSLIPIDEMIA, OBESITY and physical activity status in children
  179. High TSH level within normal range is associated with OBESITY, DYSLIPIDEMIA, hypertension, inflammation, hypercoagulability, and the metabolic syndrome: a …
  180. Association of Vitamin D Deficiency, DYSLIPIDEMIA, and OBESITY with the Incidence of Coronary Artery Diseases in Type 2 Diabetic Saudi Patients.
  181. Perilla leaf extract ameliorates OBESITY and DYSLIPIDEMIA induced by high‐fat diet
  182. Age‐specific impact of OBESITY on prevalence and costs of diabetes and DYSLIPIDEMIA
  183. Germ-free swiss webster mice on a high-fat diet develop OBESITY, hyperglycemia, and DYSLIPIDEMIA
  184. Tackling DYSLIPIDEMIA in OBESITY from a Nanotechnology Perspective. Nutrients 2022, 14, 3774
  185. DYSLIPIDEMIA versus OBESITY as predictors of ischemic stroke prognosis: a multi-center study in China
  186. Association of anthropometric indices of OBESITY with diabetes, hypertension and DYSLIPIDEMIA: a study from central India
  187. The androgen receptor confers protection against diet-induced atherosclerosis, OBESITY, and DYSLIPIDEMIA in female mice
  188. Association of area deprivation index and hypertension, diabetes, DYSLIPIDEMIA, and OBESITY: a cross-sectional study of the HABS-HD cohort
  189. Pluchea indica (L.) Less. Tea Ameliorates Hyperglycemia, DYSLIPIDEMIA, and OBESITY in High Fat Diet-Fed Mice
  190. OBESITY and DYSLIPIDEMIA among young general physicians in Iran
  191. Interaction between the genetic variant of rs696217‐ghrelin and food intake and OBESITY and DYSLIPIDEMIA
  192. Oxidized LDL Receptor 1 (OLR1) as a Possible Link between OBESITY, DYSLIPIDEMIA and Cancer
  193. The Association between breakfast skipping and the risk of OBESITY, diabetes, hypertension, or DYSLIPIDEMIA—A meta-analysis from 44 trials including 65,233 cases …
  194. … a summary score for DYSLIPIDEMIA, oxidative stress and inflammation (the DOI score) in women with polycystic ovary syndrome and its relationship with OBESITY
  195. The contribution of abdominal OBESITY and DYSLIPIDEMIA to metabolic syndrome in psychiatric patients
  196. High prevalence of DYSLIPIDEMIA irrespective of OBESITY in the cape coast metropolis of Ghana
  197. Association of serum fetuin A with truncal OBESITY and DYSLIPIDEMIA in non-diabetic hemodialysis patients
  198. The impact of OBESITY and DYSLIPIDEMIA on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study
  199. Postprandial DYSLIPIDEMIA, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with OBESITY
  200. Prevalence and risk factors of OBESITY, hypertension, DYSLIPIDEMIA and diabetes mellitus before and after adult living donor liver transplantation
  201. Atherogenic DYSLIPIDEMIA increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or OBESITY
  202. P2X7 receptor in the management of energy homeostasis: implications for OBESITY, DYSLIPIDEMIA, and insulin resistance
  203. Distinctive gut microbiota in patients with overweight and OBESITY with DYSLIPIDEMIA and its responses to long-term orlistat and ezetimibe intervention: a …
  204. Dietary protein dilution limits DYSLIPIDEMIA in OBESITY through FGF21-driven fatty acid clearance
  205. Interaction effects between characteristics of obstructive sleep apnea and OBESITY on DYSLIPIDEMIA
  206. Simultaneous inhibition of peripheral CB1R and iNOS mitigates OBESITY-related DYSLIPIDEMIA through distinct mechanisms
  207. Low-molecular-weight peptides from salmon protein prevent OBESITY-linked glucose intolerance, inflammation, and DYSLIPIDEMIA in LDLR−/−/ApoB100/100 …
  208. Exercise considerations in hypertension, OBESITY, and DYSLIPIDEMIA
  209. Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal OBESITY and DYSLIPIDEMIA
  210. Epidemiology and factor analysis of OBESITY, type II diabetes, hypertension, and DYSLIPIDEMIA (syndrome X) on the Island of Kosrae, Federated States of Micronesia
  211. ANGPTL4 gene E40K variation protects against OBESITY‐associated DYSLIPIDEMIA in participants with OBESITY
  212. … in the association of dietary patterns and metabolic parameters with OBESITY in young and middle-aged adults with DYSLIPIDEMIA and abnormal fasting plasma …
  213. Administration of Linoleoylethanolamide Reduced Weight Gain, DYSLIPIDEMIA, and Inflammation Associated with High-Fat-Diet-Induced OBESITY
  214. Rice bran attenuated OBESITY via alleviating DYSLIPIDEMIA, browning of white adipocytes and modulating gut microbiota in high-fat diet-induced obese mice
  215. OBESITY and DYSLIPIDEMIA, Importance of Body Fat Distribution
  216. Puerarin attenuates OBESITY-induced inflammation and DYSLIPIDEMIA by regulating macrophages and TNF-alpha in obese mice
  217. The role of factors of cardiometabolic risk—OBESITY and DYSLIPIDEMIA in the development of pre-diabetic disorders in people of different ages
  218. Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or OBESITY and DYSLIPIDEMIA: a randomized clinical trial
  219. The OBESITY, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic DYSLIPIDEMIA …
  220. Self-reported snoring is associated with DYSLIPIDEMIA, high total cholesterol, and high low-density lipoprotein cholesterol in OBESITY: a cross-sectional study …
  221. Relationships of accelerometer‐determined physical activity with OBESITY, hypertension, diabetes, DYSLIPIDEMIA, and health‐related quality of life in patients after liver …
  222. Metabolic disorders: Sex and gender evidence in DYSLIPIDEMIA, diabetes, and OBESITY
  223. Thyme oxymel by improving of inflammation, oxidative stress, DYSLIPIDEMIA and homeostasis of some trace elements ameliorates OBESITY induced by high …
  224. Effect of Fructooligosaccharides Fraction from Psacalium decompositum on Inflammation and DYSLIPIDEMIA in Rats with Fructose-Induced OBESITY
  225. Application of OBESITY indicators based on body fat in the screening of persistent DYSLIPIDEMIA among school-aged children
  226. Effect and Correlation of Rosa roxburghii Tratt Fruit Vinegar on OBESITY, DYSLIPIDEMIA and Intestinal Microbiota Disorder in High-Fat Diet Mice
  227. Leptin decreases the expression of low-density lipoprotein receptor via PCSK9 pathway: linking DYSLIPIDEMIA with OBESITY
  228. Lactobacillus fermentum CQPC07 attenuates OBESITY, inflammation and DYSLIPIDEMIA by modulating the antioxidant capacity and lipid metabolism in high-fat …
  229. 10 Visceral OBESITY, Insulin Resistance, and DYSLIPIDEMIA: Contribution of Endurance Exercise Training to the Treatment of the Plurimetabolic Syndrome
  230. High prevalence of OBESITY in rheumatoid arthritis patients: association with disease activity, hypertension, DYSLIPIDEMIA and diabetes, a multi-center study
  231. Genetic variants of resistin and its plasma levels: Association with OBESITY and DYSLIPIDEMIA related to type 2 diabetes susceptibility
  232. Impacts of types and degree of OBESITY on non-alcoholic fatty liver disease and related DYSLIPIDEMIA in Chinese school-age children?
  233. … confers an increased risk of OBESITY and hypercholesterolemia, while T allele of the rs3856806 polymorphism displays a protective role against DYSLIPIDEMIA …
  234. Effects of coix seed oil on high fat diet-Induced OBESITY and DYSLIPIDEMIA
  235. Endogenous ω-3 polyunsaturated fatty acid production confers resistance to OBESITY, DYSLIPIDEMIA, and diabetes in mice
  236. Effects of high-fat diet and fructose-rich diet on OBESITY, DYSLIPIDEMIA and hyperglycemia in the WBN/Kob-Leprfa rat, a new model of type 2 diabetes mellitus
  237. Effect and correlation of Cordyceps guangdongensis ethanolic extract on OBESITY, DYSLIPIDEMIA and gut microbiota dysbiosis in high-fat diet mice
  238. Trends In Prevalence Of DYSLIPIDEMIA And Severe DYSLIPIDEMIA In Middle-Aged Men With Normal Waist Circumference And Visceral OBESITY
  239. Prevalence of OBESITY and DYSLIPIDEMIA in middle-aged men and women in Tanzania, Africa: relationship with resting energy expenditure and dietary factors
  240. Association between the frequency of dining out and the risk of OBESITY, diabetes mellitus, and DYSLIPIDEMIA among Korean adults
  241. Hypolipidemic and anti‐OBESITY effects of hydroalcoholic extract of Brazilian red propolis in a rodent model of DYSLIPIDEMIA
  242. Is central OBESITY, hyperinsulinemia and DYSLIPIDEMIA associated with high-grade prostate cancer? A descriptive cross-sectional study
  243. ASSOCATION OF NON–MODIFIABLE RISK FACTORS (DIABETES, HYPERTENSION AND OBESITY) WITH DYSLIPIDEMIA IN STROKE PATIENTS AT A …
  244. Pediococcus acidilactici (pA1c®) alleviates OBESITY-related DYSLIPIDEMIA and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota
  245. The role of ultra-processed food intake and development of DYSLIPIDEMIA and OBESITY in middle-aged and older adults: A longitudinal community-based study
  246. Fármacos usados no tratamento da dislipidemia e da obesidade: foco no tecido adiposo/Drugs involved in DYSLIPIDEMIA and OBESITY treatment: focus on …
  247. Association of OBESITY indexes with DYSLIPIDEMIA among adult residents in Shaanxi province: a cross-sectional survey
  248. Anti-TNF-α agent tamarind kunitz trypsin inhibitor improves lipid profile of wistar rats presenting DYSLIPIDEMIA and diet-induced OBESITY regardless of PPAR-γ …
  249. OBESITY and DYSLIPIDEMIA in behaviorally HIV-infected young women: Adolescent Trials Network study 021
  250. Vitamin D Levels and Risk of DYSLIPIDEMIA among US Children with Diabetes and OBESITY
  251. A case report of nonalcoholic fatty liver disease with OBESITY and DYSLIPIDEMIA
  252. A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, OBESITY, metabolic syndrome, and DYSLIPIDEMIA
  253. … ANGPTL3, apoC-III, and apoB48 DYSLIPIDEMIA, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with OBESITY
  254. OBESITY-related DYSLIPIDEMIA associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent
  255. Genetic control of OBESITY, glucose homeostasis, DYSLIPIDEMIA and fatty liver in a mouse model of diet-induced metabolic syndrome
  256. … RISK STRATEGIES FOR DYSLIPIDEMIA IN RHEUMATOID ARTHRITIS PATIENTS: DATA FROM THE CARDIOVASCULAR OBESITY AND RHEUMATIC DISEASES …
  257. Antrodia cinnamomea Prevents OBESITY, DYSLIPIDEMIA, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling
  258. The association of serum testosterone with DYSLIPIDEMIA is mediated by OBESITY: the Henan Rural Cohort Study
  259. DYSLIPIDEMIA in children with type 2 diabetes vs. OBESITY
  260. The FOXC2 C‐512T Polymorphism Is Associated with OBESITY and DYSLIPIDEMIA
  261. DYSLIPIDEMIA and OBESITY 2011. Similarities and differences
  262. Studies on the unique properties of resistant starch and chito-oligosaccharide complexes for reducing high-fat diet-induced OBESITY and DYSLIPIDEMIA in rats
  263. Beta‐glucan suppresses high‐fat‐diet‐induced OBESITY by attenuating DYSLIPIDEMIA and modulating obesogenic marker expressions in rats
  264. Associations of daily sleep duration and dietary macronutrient consumption with OBESITY and DYSLIPIDEMIA in Koreans: a cross-sectional study
  265. A review of genus Garcinia sp as potential sources of therapies against OBESITY and DYSLIPIDEMIA
  266. Different contributions of DYSLIPIDEMIA and OBESITY to the natural history of type 2 diabetes: 3-year cohort study in China
  267. The associations between blood and urinary concentrations of metal metabolites, OBESITY, hypertension, type 2 diabetes, and DYSLIPIDEMIA among US adults …
  268. Whole barley prevents OBESITY and DYSLIPIDEMIA without the involvement of the gut microbiota in germ free C57BL/6J obese mice
  269. DYSLIPIDEMIA and endothelial dysfunction in the pathogenesis of nonalcoholic steatohepatitis in patients with OBESITY and chronic kidney disease
  270. Do uncontrolled hypertension, diabetes, DYSLIPIDEMIA, and OBESITY mediate the relationship between health literacy and chronic kidney disease complications …
  271. Usefulness of impedanciometry for the assessment of OBESITY in a high risk DYSLIPIDEMIA screening unit
  272. Effect of DYSLIPIDEMIA, OBESITY, and atopic status on exhaled and alveolar nitric oxide in asthmatic children
  273. Leptin and OBESITY: Understanding the Impact on DYSLIPIDEMIA
  274. Central OBESITY and DYSLIPIDEMIA in pediatric patients with psoriasis: An observational study from India
  275. … -Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, OBESITY, central OBESITY, and DYSLIPIDEMIA
  276. The association between OBESITY phenotypes and early renal function decline in adults without hypertension, DYSLIPIDEMIA, and diabetes
  277. Association of DYSLIPIDEMIA and OBESITY After Menopause
  278. … ACID CONTENT AND THE EFFECT OF AQUEOUS EXTRACT OF Portulaca oleraceaIN HIGH-FAT DIET-INDUCED OBESITY, DYSLIPIDEMIA AND LIVER DAMAGE …
  279. Type 2 diabetes mellitus, hypertension, DYSLIPIDEMIA and OBESITY: a systematic comparison of their impact on cognition
  280. DYSLIPIDEMIA-in-obesity”>DYSLIPIDEMIA in OBESITY
  281. OBESITY and DYSLIPIDEMIA predict cardiac allograft vasculopathy and graft loss in children and adolescents post‐heart transplant: A PHTS multi‐institutional analysis
  282. Association of hair polychlorinated biphenyls and multiclass pesticides with OBESITY, diabetes, hypertension and DYSLIPIDEMIA in NESCAV study
  283. Alström syndrome: renal findings in correlation with OBESITY, insulin resistance, DYSLIPIDEMIA and cardiomyopathy in 38 patients prospectively evaluated at the NIH …
  284. Relationship of Xba1 and EcoR1 polymorphisms of apolipoprotein-B gene to DYSLIPIDEMIA and OBESITY in Asian Indians in North India.
  285. Prevalence of OBESITY, DYSLIPIDEMIA and Diabetes Mellitus in Patients with Gastrojejunostomy.
  286. DYSLIPIDEMIA in visceral OBESITY: pathophysiological mechanisms, clinical implications and therapy
  287. Effect of overweight and OBESITY on glucose intolerance and DYSLIPIDEMIA in Saudi Arabia, epidemiological study
  288. Long-Term Ingestion of Monosodium L-Glutamate Did Not Induce OBESITY, DYSLIPIDEMIA or Insulin Resistance: A Two-Generation Study in Mice
  289. OBESITY and DYSLIPIDEMIA. Nature of an association
  290. Mechanism of DYSLIPIDEMIA in OBESITY—unique regulation of ileal villus cell brush border membrane sodium–bile acid cotransport
  291. Sex-dependent DYSLIPIDEMIA and neuro-humoral alterations leading to further cardiovascular risk in juvenile OBESITY
  292. Correlation between sarcopenic OBESITY and DYSLIPIDEMIA in the young and middle aged adults
  293. The OBESITY, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic DYSLIPIDEMIA
  294. DYSLIPIDEMIA_in_hiv_patients_on.3.aspx”>Central OBESITY & DYSLIPIDEMIA in HIV patients on antiretroviral therapy
  295. Correlation of A2bAR and KLF4/KLF15 with OBESITY–DYSLIPIDEMIA Induced Inflammation in Uygur Population
  296. Association of NCOA2 gene polymorphisms with OBESITY and DYSLIPIDEMIA in the Chinese Han population
  297. Berberine is as effective as the anti-OBESITY drug Orlistat in ameliorating betel-nut induced DYSLIPIDEMIA and oxidative stress in mice
  298. PREVALENCE OF CENTRAL OBESITY AND DYSLIPIDEMIA IN TYPE 2 DIABETICS
  300. Malus hupehensis leaves extract attenuates OBESITY, inflammation, and DYSLIPIDEMIA by modulating lipid metabolism and oxidative stress in high‐fat diet‐induced …
  301. ApoB‐lipoprotein remnant DYSLIPIDEMIA and high‐fat meal intolerance is associated with markers of cardiometabolic risk in youth with OBESITY
  302. … polyunsaturated fatty acids has neutral effects on glycemic control but improves DYSLIPIDEMIA in type 2 diabetic patients with abdominal OBESITY: a randomized, double …
  303. OBESITY, DYSLIPIDEMIA and cholesterol gallstone disease during one year of Antarctic residence
  304. Breakfast intake effect on the association between fast-food consumption and the risk of OBESITY and DYSLIPIDEMIA in Korean adults aged 20–39 years based …
  305. Influence of OBESITY on atherogenic DYSLIPIDEMIA in women with polycystic ovary syndrome
  306. Skin tags: a link between lesional mast cell count/tryptase expression and OBESITY and DYSLIPIDEMIA
  307. Sarcopenic OBESITY and DYSLIPIDEMIA response to selective exercise program after liver transplantation
  308. … to body weight ratio predicts the incident nonalcoholic fatty liver disease in nonelderly Chinese without OBESITY and DYSLIPIDEMIA: a retrospective study
  309. … ayurvedic beliefs in food intake & non-communicable disease risk factors like hypertension, diabetes mellitus, OBESITY & DYSLIPIDEMIA among middle aged …
  310. Central OBESITY as a reliable predictor for hypertension and DYSLIPIDEMIA: Tehran Lipid Glucose Study
  311. Cymbopogon schoenanthus (L) extract ameliorates high fat diet-induced OBESITY and DYSLIPIDEMIA via reducing expression of lipogenic and thermogenic proteins
  312. Walnut peptide alleviates OBESITY, inflammation and DYSLIPIDEMIA in mice fed a high-fat diet by modulating the intestinal flora and metabolites
  313. DYSLIPIDEMIA,_and_insulin.8.aspx”>Assessment of OBESITY, DYSLIPIDEMIA, and insulin resistance in idiopathic hirsutism: a case–control study
  314. Chronic statin treatment does not impair exercise lipolysis or fat oxidation in exercise-trained individuals with OBESITY and DYSLIPIDEMIA
  315. OBESITY, Lipid profiles and prevalence of DYSLIPIDEMIA amongst diabetic patients in Warangal
  316. High lipolytic activity and DYSLIPIDEMIA in a spontaneous hypertensive/NIH corpulent (SHR/N-cp) rat: a genetic model of OBESITY and type 2 diabetes mellitus.
  317. A genome-wide search for gene-by-OBESITY interaction loci of DYSLIPIDEMIA in Koreans shows diverse genetic risk alleles
  318. Long-term Bisphenol S exposure induced gut microbiota dysbiosis, OBESITY, hepatic lipid accumulation, intestinal lesions and DYSLIPIDEMIA in mice
  319. Favorable genotypes of type III interferon confer risk of DYSLIPIDEMIA in the population with OBESITY
  320. Joint effects of hypertension, smoking, DYSLIPIDEMIA and OBESITY and angiotensin-converting enzyme DD genotype on albuminuria in Taiwanese patients with type 2 …
  321. Postnatal Consumption of Black Bean Powder Protects against OBESITY and DYSLIPIDEMIA in Male Adult Rat Offspring from Obese Pregnancies
  322. Carob Extract (Ceratonia siliqua L.): Effects on DYSLIPIDEMIA and OBESITY in a High-Fat Diet-Fed Rat Model
  323. Central OBESITY in males affected by a DYSLIPIDEMIA-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster
  324. Indices of OBESITY, DYSLIPIDEMIA, and insulin resistance in apparently healthy Caribbean subjects
  325. Effect of Prosthechea karwinskii (Orchidaceae) on OBESITY and DYSLIPIDEMIA in Wistar rats
  326. OBESITY and DYSLIPIDEMIA in Tunisian bipolar subjects
  327. Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes DYSLIPIDEMIA and OBESITY
  328. Medical expenditure attributable to overweight and OBESITY in adults with hypertension, diabetes and DYSLIPIDEMIA: evidence from Korea National Health and Nutrition …
  329. OBESITY, DYSLIPIDEMIA and insulin resistance in survivors of childhood cancer
  330. … on chronic diseases: cardiovascular diseases, oxidative stress, DYSLIPIDEMIA, diabetes mellitus, blood pressure, cancer, neurodegenerative disease and OBESITY
  331. OBESITY and DYSLIPIDEMIA
  332. Insulin resistance: the metabolic link between non-insulin-dependent diabetes mellitus, OBESITY, hypertension, DYSLIPIDEMIA, and atherosclerotic cardiovascular …
  333. Monomeric GLP-1/GIP/glucagon triagonism corrects OBESITY, hepatosteatosis, and DYSLIPIDEMIA in female mice
  334. Myrtle Berries Seeds Prevent DYSLIPIDEMIA, Inflammation, and Excessive Cardiac Reactive Oxygen Species Production in Response to High-Fat Diet–Induced OBESITY
  335. Differential effects of plant and animal fats on OBESITY‐induced DYSLIPIDEMIA and atherosclerosis in Ldlr−/−. Leiden mice
  336. Silent pituitary adenoma and metabolic disorders: OBESITY, abnormal glucose tolerance, hypertension and DYSLIPIDEMIA
  337. Relationship between OBESITY, DYSLIPIDEMIA and type 2 diabetes
  338. Gas chromatography-mass spectrometry pilot study to identify volatile organic compound biomarkers of childhood OBESITY with DYSLIPIDEMIA in exhaled breath
  339. The Effect of Central OBESITY, Smoking, and Fried Food Consumption on DYSLIPIDEMIA in Adults: A Prospective Cohort Study
  340. Prevalence and risk factors for DYSLIPIDEMIA in diabetics with overweight or OBESITY
  341. Association between diet quality and prevalence of OBESITY, DYSLIPIDEMIA, and insulin resistance: The Filipino Womens Diet and Health Study (FiLWHEL)
  342. Small-molecule inhibitors of FABP4/5 ameliorate DYSLIPIDEMIA but not insulin resistance in mice with diet-induced OBESITY
  343. Probiotics improve OBESITY-associated DYSLIPIDEMIA and insulin resistance in high-fat diet-fed rats
  344. Monocyte DPP4 expression in human atherosclerosis is associated with OBESITY and DYSLIPIDEMIA
  345. DYSLIPIDEMIA is a major factor in stem cell damage induced by uncontrolled long-term type 2 diabetes and OBESITY in the rat, as suggested by the effects on stem cell …
  346. Utility of OBESITY and metabolic DYSLIPIDEMIA (a non‐insulin based determinate of the metabolic syndrome and insulin resistance) in predicting arterial stiffness
  347. Ameliorating effects of Sporidiobolus pararoseus extract on DYSLIPIDEMIA in mice with high fat diet induced OBESITY
  348. No association found between the Ala54Thr polymorphism of FABP2 gene and OBESITY and OBESITY with DYSLIPIDEMIA in Japanese schoolchildren
  349. Treatment of diabetes, OBESITY, DYSLIPIDEMIA, and related disorders with GPR119 agonists
  350. OBESITY and DYSLIPIDEMIA: importance of body fat distribution
  351. Sex hormone-binding globulin is associated with OBESITY and DYSLIPIDEMIA in prepubertal children
  352. Association of retinol binding protein-4 (RBP4) with glycemia, DYSLIPIDEMIA, hypertension, and OBESITY in type 2 diabetic Iraqi patients
  353. Prevalence of OBESITY, hypertension and DYSLIPIDEMIA in rural aboriginal groups in Chile
  354. Effect of herbal extracts and Saroglitazar on high-fat diet-induced OBESITY, insulin resistance, DYSLIPIDEMIA, and hepatic lipidome in C57BL/6J mice
  355. Oral L-Citrulline Supplementation Improves Fatty Liver and DYSLIPIDEMIA in Adolescents with Abdominal OBESITY: A Parallel, Double-Blind, Randomized …
  356. Switching from clozapine to paliperidone palmitate-3-monthly improved OBESITY, hyperglycemia and DYSLIPIDEMIA lowering antipsychotic dose equivalents in a …
  357. Associations of the SREBF2 Gene and INSIG2 Polymorphisms with OBESITY and DYSLIPIDEMIA in Thai Psychotic Disorder Patients Treated with Risperidone
  358. Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates DYSLIPIDEMIA, insulin resistance, and OBESITY for life-time
  359. DYSLIPIDEMIA-and-obesity-in-ischemic-stroke.pdf”>DYSLIPIDEMIA and OBESITY in Ischemic Stroke
  360. DYSLIPIDEMIA_IN_CHILDREN_WITH_CHRONIC_HEPATITIS/links/6388b6002c563722f229825a/OBESITY-AND-DYSLIPIDEMIA-IN-CHILDREN-WITH-CHRONIC-HEPATITIS.pdf”>OBESITY AND DYSLIPIDEMIA IN CHILDREN WITH CHRONIC HEPATITIS
  361. Effect of serum gamma-glutamyltransferase and OBESITY on the risk of DYSLIPIDEMIA and poor glycemic control in type 2 diabetic patients: cross-sectional findings from …
  362. Drug combinations for DYSLIPIDEMIA and OBESITY treatment in metabolic syndrome
  363. Type 2 diabetes mellitus increases risk of erectile dysfunction independent of OBESITY and DYSLIPIDEMIA: A Mendelian randomization study
  364. Association Between Diet Quality and Prevalence of OBESITY, DYSLIPIDEMIA, and Insulin Resistance Among Filipino Immigrant Women in Korea: The Filipino …
  365. Additive effect of OBESITY and DYSLIPIDEMIA on wheezing in korean adults: a nationwide representative survey study
  366. Effect of replacing sardine oil with margarine on DYSLIPIDEMIA, dysglycemia and redox status of adipose tissue in high-fat diet-induced OBESITY in Wistar rats
  367. Tissue changes in the development of fatty liver by chronic ingestion of sucrose associated with OBESITY and DYSLIPIDEMIA in rats
  368. A combination of Omega-3 PUFAs and COX inhibitors: A novel strategy to manage OBESITY-linked DYSLIPIDEMIA and adipose tissue inflammation
  369. Prevalence of OBESITY and correlation between OBESITY and DYSLIPIDEMIA in elderly population in south-west Seoul
  370. OBESITY-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with DYSLIPIDEMIA rather than hyperinsulinemia
  371. Hypertension and DYSLIPIDEMIA in Pediatric OBESITY
  372. The anti-inflammatory and antioxidants effects of micronized fenofibrate in patients with visceral OBESITY and DYSLIPIDEMIA
  373. Correlation of Parkinson’s disease with diabetes mellitus, OBESITY, DYSLIPIDEMIA and their association with severity of disease.
  374. Virgin coconut oil (VCO) ameliorates high fat diet (HFD)-induced OBESITY, DYSLIPIDEMIA and bestows cardiovascular protection in rats
  375. The Effect of Low Carbohydrate Diets on Glycemia Control, OBESITY, and DYSLIPIDEMIA in Adults with Type 2 Diabetes.
  376. Hypothyroidism as a risk factor for DYSLIPIDEMIA and OBESITY
  377. Screening for DYSLIPIDEMIA and expedience of statin therapy for the citizens of Transcarpathia valley regions with overweight and OBESITY
  378. Serum retinol-binding protein 4 correlates with OBESITY, insulin resistance, and DYSLIPIDEMIA in HIV-infected subjects receiving highly active antiretroviral therapy
  379. Cystic fibrosis: From protein-energy malnutrition to OBESITY with DYSLIPIDEMIA
  380. Effect of Mind-Body medicine intervention and intermittent fasting on morbid OBESITY with DYSLIPIDEMIA: A Case Report
  381. Dietary 23–hydroxy ursolic acid protects against atherosclerosis and OBESITY by preventing DYSLIPIDEMIA-induced monocyte priming and dysfunction
  382. G protein-coupled receptor 12 deficiency results in DYSLIPIDEMIA and OBESITY in mice
  383. New and emerging pharmacologic therapies for type 2 diabetes, DYSLIPIDEMIA, and OBESITY
  384. Egg yolk phosphatidylcholine is more effective than soybean phosphatidylcholine in improving DYSLIPIDEMIA of OBESITY in mice fed a high-fat diet
  385. Apolipoprotein AV level may contribute to the development of OBESITY-associated DYSLIPIDEMIA
  386. OBESITY, DYSLIPIDEMIA, and cardiovascular disease: A joint expert review from the OBESITY Medicine Association and the National Lipid Association 2024
  387. OBESITY and abdominal adiposity in diabetic DYSLIPIDEMIA
  388. Number of colony-forming unit-Hill colonies among children and teenagers with OBESITY, DYSLIPIDEMIA and breastfeeding history
  389. Association of Hypertension with Cluster of OBESITY, Abnormal glucose and DYSLIPIDEMIA in Korean Urban Population.
  390. OBESITY-Associated DYSLIPIDEMIA Is Moderated by Habitual Intake of Marine-Derived n-3 Polyunsaturated Fatty Acids in Yup’ik Alaska Native People: A Cross …
  391. The global problem: OBESITY and DYSLIPIDEMIA.
  392. DYSLIPIDEMIA and abdominal OBESITY: mechanisms and characteristics (Part I)
  393. OBESITY and its metabolic complications: the role of adipokines and the relationship between OBESITY, inflammation, insulin resistance, DYSLIPIDEMIA and nonalcoholic …
  394. Puerarin Attenuates OBESITY-Induced Inflammation and DYSLIPIDEMIA by Regulating Macrophages and TNF-Alpha in Obese Mice. Biomedicines 2022; 10: 175
  395. Impacts of types and degree of OBESITY on non-alcoholic fatty liver disease and related DYSLIPIDEMIA in Chinese school-age children?
  396. DYSLIPIDEMIA-diabetes-and-hypoglycemia.html”>Perturbations in Cellular Bioenergetics: Childhood OBESITY, DYSLIPIDEMIA, Diabetes and Hypoglycemia
  397. Impact of DYSLIPIDEMIA and OBESITY on the incidence of cardiotoxicity in breast cancer patients treated with anthracyclines and Trastuzumab
  398. DYSLIPIDEMIA-and-diabetes-mellitus-as-risk-factors-in-cholelithiasis,175943,0,2.html”>OBESITY, DYSLIPIDEMIA, and diabetes mellitus as risk factors in cholelithiasis
  399. DYSLIPIDEMIA__Epidemiology,.8.aspx”>OBESITY and DYSLIPIDEMIA: Epidemiology, Physiology, and Effects of Weight Loss
  400. Multivariate analysis of genomics data to identify potential pleiotropic genes for type 2 diabetes, OBESITY and DYSLIPIDEMIA using Meta-CCA and gene-based …
  401. Acetate wheat starch improving blood glucose response and bilan lipid on OBESITY DYSLIPIDEMIA mice
  402. Screening for DYSLIPIDEMIA based on family history combined with OBESITY in children
  403. Circulating miR-3659 may be a potential biomarker of DYSLIPIDEMIA in patients with OBESITY
  404. Correlation Between Life Style and DYSLIPIDEMIA with Impaired Fasting Blood Sugar in State Junior High School and State Senior High School Having Central OBESITY
  405. The ominous link between OBESITY and abdominal adiposity with diabetes and diabetic DYSLIPIDEMIA in diabetic population of developing country.
  406. OBESITY Heterogeneity and DYSLIPIDEMIA in Urbanizing China
  407. OBESITY, DYSLIPIDEMIA, and sleep disorders: complexity requires complementary analysis
  408. Recent advances in stearoyl-CoA desaturase 1 inhibitors for DYSLIPIDEMIA and OBESITY
  409. Visceral OBESITY induced by a high-calorie diet leads to DYSLIPIDEMIA, insulin resistance and impairs adrenal function in male rabbits
  410. Effect of the Interaction Between Overweight/OBESITY and DYSLIPIDEMIA on the Risk of Hypertension in Tibetan Population Living in Tibet
  411. Analysis on prevalence of overweight and OBESITY and their relation with diabetes, hypertension, DYSLIPIDEMIA among adults in Pinghu City
  412. Effects of ezetimibe on visceral fat in patients with DYSLIPIDEMIA complicated by OBESITY or metabolic syndrome
  413. OBESITY, lifestyle behaviors and DYSLIPIDEMIA among Chinese adults aged 45 and older
  414. Association of Anthropometric Indices of OBESITY and Body Fat Composition with Diabetes Mellitus, Hypertension, and DYSLIPIDEMIA: A Case-control Study.
  415. Prevention of aqueous extract from chrysanthemum morifolium of Chuju against high-fat diet induced OBESITY and DYSLIPIDEMIA.
  416. DYSLIPIDEMIA in adolescents living in a city of Paraná and association with abdominal OBESITY
  417. … –a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android OBESITY, essential hypertension, DYSLIPIDEMIA …
  418. Chronic treatment with anti-GIPR mAb alone and combined with DPP-4 inhibitor correct OBESITY, DYSLIPIDEMIA and nephropathy in rodent animals
  419. The influence of OBESITY and DYSLIPIDEMIA on ghrelin production in women of reproductive age
  420. Increased body mass index increase and insulin resistance parameters in DYSLIPIDEMIA. Risk and positive correlation in essential OBESITY
  421. Longer duration of overweight/OBESITY associated with higher odds of developing hypertension or DYSLIPIDEMIA: The Coronary Artery Risk Development in Young …
  422. Association of hypertension, diabetes, DYSLIPIDEMIA, and metabolic syndrome with overweight/OBESITY.
  423. Relationship between abdominal OBESITY and DYSLIPIDEMIA in postmenopausal women in a community of Suzhou City in 2014
  424. … of Cuban Policosanol (Raydel®, 20 mg) and Intensive Exercise for 12 Weeks Resulted in Improvements in OBESITY, Hypertension, and DYSLIPIDEMIA without a Decrease …
  425. DYSLIPIDEMIA_IN_WOMEN_LIVING_IN_THE.569.aspx”>OBESITY AND DYSLIPIDEMIA IN WOMEN LIVING IN THE CROATIAN RURAL AREA DAMAGED BY AN EARTHQUAKE.“THE SILENT KILLER HUNT”-CROATIAN …
  426. Association of Cigarette Smoking with DYSLIPIDEMIA and Abdominal OBESITY as Cardiovascular Risk Factors among Young Adults
  427. … , abdominal, and somatic variations by race in men with OBESITY resolve after Laparoscopic Roux-en-Y gastric bypass (LRYGB): DYSLIPIDEMIA and psychologicals by …
  428. Treatment of OBESITY with chorionic gonadotropins. Relations between OBESITY, DYSLIPIDEMIA and arthero-arteriosclerosis
  429. Chatuphalatika, a Thai herbal formula, ameliorate OBESITY and DYSLIPIDEMIA in high-fat diet fed mice
  430. DYSLIPIDEMIA-obesity-hitesh-malhotra-peeyush-kaushik-anjoo-kamboj-rupesh-gautam”>Role of β-Glucans in DYSLIPIDEMIA and OBESITY
  431. DYSLIPIDEMIA IN OBESITY: UNRAVELING MECHANISMS AND IMPLICATIONS FOR CHRONIC NONCOMMUNICABLE DISEASES MANAGEMENT.
  432. Effects of Insulin Level on DYSLIPIDEMIA in Children with Simple OBESITY
  433. Features of the immune status in patients with coronary heart disease with OBESITY and atherogenic DYSLIPIDEMIA
  434. … PREDICTS INCREASED SYSTEMIC INFLAMMATION, DYSLIPIDEMIA, AND HEPATIC STEATOSIS INDEPENDENT OF OBESITY AND METABOLIC SYNDROME
  435. Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With DYSLIPIDEMIA, Insulin Resistance, OBESITY, and Chronic Inflammation …
  436. DYSLIPIDEMIA in OBESITY: pathogenetic considerations and our experience
  437. Hypercaloric Cafeteria Diet-Induces OBESITY, DYSLIPIDEMIA, Insulin Resistance, Inflammation and Oxidative Stress in Wistar Rats
  438. OBESITY, DYSLIPIDEMIA, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer.
  439. Effects of anti-diabetic therapy on overweight/OBESITY and DYSLIPIDEMIA: traditional hypoglycemic agents (metformin, sulfonylureas, thiazolidinediones) versus …
  440. Corrigendum: The interplay of OBESITY, DYSLIPIDEMIA and immune dysfunction: a brief overview on pathophysiology, animal models, and nutritional modulation
  441. A Study of the Effect on OBESITY and DYSLIPIDEMIA in Kidney-hypofunction Animal Model Induced by Unilateral Ureteral Obstruction
  442. Amino acids and OBESITY, diabetes, and DYSLIPIDEMIA in pigs and other mammals
  443. Insulin resistance as a common clinical feature in diabetes mellitus, OBESITY, hypertension, DYSLIPIDEMIA, and atherosclerosis deserves more attention in …
  444. A coding variant in SULT1A2 gene: association with OBESITY and DYSLIPIDEMIA in southern Chinese adults
  445. Association of Eating out Frequency with the Risks of OBESITY, Diabetes, and DYSLIPIDEMIA Among Korean Adults (P18-058-19)
  446. Association of OBESITY and insulin resistance with DYSLIPIDEMIA in Indian women with polycystic ovarian syndrome
  447. To study the thyroid status in type 2 DM and its possible relation with hyperglycaemia, OBESITY and DYSLIPIDEMIA
  448. Weight gain and OBESITY are associated with DYSLIPIDEMIA, hyperuricemia, and liver dysfunction in Japanese young male workers
  449. … Trial of Pitavastatin Calcium to Treat Combined DYSLIPIDEMIA of OBESITY in Adolescents-The Pediatric Heart Network DYSLIPIDEMIA of OBESITY Intervention in Teens (Do …
  450. Effects of Coix Seed Oil on High Fat Diet-Induced OBESITY and DYSLIPIDEMIA. Foods 2022, 11, 3267
  451. The Evaluation of DYSLIPIDEMIA and OBESITY
  452. Combined Effects of DYSLIPIDEMIA and OBESITY Parameters on The Estimated Glomerular Filtration Rate in a Middle-Aged Population
  453. Individual and Combined Effect of Famine Exposure and OBESITY Parameters on DYSLIPIDEMIA in Mid-Aged and Older Adult: A Population-Based Cross-Sectional …
  454. DYSLIPIDEMIA, OBESITY and coronavirus disease (COVID-)
  455. Does bariatric surgery ameliorate the DYSLIPIDEMIA of OBESITY? Observations from five years of follow-up after gastric banding
  456. OBESITY diabetes and DYSLIPIDEMIA as determinants of immune checkpoint inhibitors response in non-small cell lung cancer.
  457. Effect of Dill Seed Cake on DYSLIPIDEMIA and Hormonal Imbalance against High Fructose-diet Induced OBESITY in Rats.
  458. Abstract P516: Vascular Risk Assessment in Youth With Familial Hypercholesterolemia and Combined DYSLIPIDEMIA of OBESITY
  459. Management of OBESITY-associated DYSLIPIDEMIA: an approach based on food choices
  460. Stilbenes: Beneficial Effects of Resveratrol Metabolites in OBESITY, DYSLIPIDEMIA, Insulin Resistance, and Inflammation
  461. Influence of hypercaloric diets on the parameters of OBESITY, DYSLIPIDEMIA and hyperglycemia in rats.
  462. ROLE OF VYOSHADI GUGGULU IN MEDOROG (OBESITY) ASSOCIATED WITH DYSLIPIDEMIA: A CASE STUDY
  463. Effect of Antipsychotic Polypharmacy On OBESITY, Hypertension, DYSLIPIDEMIA, and Diabetes
  464. A Study of the Association of Abdominal OBESITY, DYSLIPIDEMIA and Glycemic Status in Pre-hypertensive Young Adults of a Medical University.
  465. DYSLIPIDEMIA+obesity&ots=pr4Ql7FGJg&sig=01fmdb2bdqbSQiM9xx_v00l-T2w”>New potential Beta-3 adrenergic agonists with Beta-phenylethylamine structure, synthesized for the treatment of DYSLIPIDEMIA and OBESITY
  466. Effects of DYSLIPIDEMIA in Diet-Induced OBESITY and Aging on the Meibomian Gland and Ocular Surface
  467. Trastuzumab-related cardiotoxicity in patients with breast cancer with comorbidities of OBESITY, DYSLIPIDEMIA, and diabetes.
  468. Fixed combination antihypertensive treatment in hypertensive patients with OBESITY and DYSLIPIDEMIA affects the heart and vascular remodeling
  469. An Observational Study of Correlation Between Risk Factors-OBESITY, Hypertension, Diabetes, DYSLIPIDEMIA with Carotid Intima Media Thickness In Patients …
  470. Prevalence and Correlates of OBESITY and DYSLIPIDEMIA in Psoriasis: Insights from a Cross-Sectional Study
  471. Abstract P2-07-06: OBESITY, DYSLIPIDEMIA, and diabetes as risk factors for trastuzumab-related cardiotoxicity in breast cancer patients
  472. Prevalence of DYSLIPIDEMIA and OBESITY among college students in Kuwait
  473. OBESITY, DYSLIPIDEMIA, and Sleep Disorders: Response
  474. DYSLIPIDEMIA, OBESITY, Insulin Resistance and Atherosclerosis in LDL-Receptor Deficient Rats
  475. Obstructive Sleep Apnea, OBESITY And DYSLIPIDEMIA
  476. The effect of ageing and OBESITY on the expression of DYSLIPIDEMIA in children from FCH families.
  477. The effect of ageing and OBESITY on the expression of DYSLIPIDEMIA in children from FCH families
  478. Therapeutic Evaluation of Vrikshamla (Garcinia Cambogia) in the Management of Sthoulya (OBESITY) WSR DYSLIPIDEMIA a Case Report.(2022)
  479. Clinical Safety of Selected Ayurvedic Formulations in OBESITY and DYSLIPIDEMIA
  480. DYSLIPIDEMIA-risks-and-severity-of-obesity-among-adolescents-in-united-arab-emirates,164291,0,2.html”>DYSLIPIDEMIA risks and severity of OBESITY among adolescents in united arab emirates
  481. OBESITY and DYSLIPIDEMIA in Chinese patients with obstructive sleep apnea
  482. Risk factors of overweight or OBESITY and their relationship with DYSLIPIDEMIA among aerospace professional staff
  483. Prevalence of Diabetes Hypertension, OBESITY, DYSLIPIDEMIA and Metabolic Syndrome in Urban South Indian Population
  484. Frequency of DYSLIPIDEMIA in pediatric patients with overweight and OBESITY
  485. The impact of biological stress systems and lifestyle on DYSLIPIDEMIA and OBESITY in anxiety and depression
  486. Postprandial DYSLIPIDEMIA and Intestinal Dysfunction in Adolescents with OBESITY and Insulin Resistance
  487. OBESITY and DYSLIPIDEMIA are associated with partially reversible modifications to DNA hydroxymethylation of apoptosis-and senescence-related genes in …
  488. Endothelin-1 in OBESITY Associated Insulin Resistance and DYSLIPIDEMIA
  489. Association between OBESITY, DYSLIPIDEMIA and insulin resistance with suspected fatty liver disease in Greek children with excess weight
  490. DYSLIPIDEMIA-related-metabolic-abnormalities-jean-pierre-despre%C2%B4s”>Abdominal OBESITY As a Therapeutic Target to Manage the Atherogenic DYSLIPIDEMIA and Related Metabolic Abnormalities
  491. Association between OBESITY and therapeutic goal attainment in patients with concomitant hypertension and DYSLIPIDEMIA
  492. The prevalence of hypertension, OBESITY and DYSLIPIDEMIA in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang.
  493. The OBESITY paradox in the distribution of DYSLIPIDEMIA in obese versus non-obese patients of CAD in Gujarati population.
  494. IT’S COCOA EXTRACT BENEFIT TO MALE DYSLIPIDEMIA ATHEROGENIC CENTRAL OBESITY?
  495. OBESITY DYSLIPIDEMIA: the effect of central nervous system neuropeptide Y on hepatic lipoprotein metabolism
  496. … difference in the association of dietary patterns and metabolic parameters with OBESITY in young and middle-aged adults with DYSLIPIDEMIA and abnormal fasting …
  497. … SR-B1 Deficiency Increased Inflammatory DYSLIPIDEMIA and Adipocyte Hypertrophy and Attenuated the Hepatic Steatosis in Murine Diet-Induced OBESITY
  498. DYSLIPIDEMIA,_and_Obesity_Are.1392.aspx”>Aging, Smoking, DYSLIPIDEMIA, and OBESITY Are Independently Associated With the Prevalence of Colorectal Neoplasia in Japan: Analyses of Comprehensive Health …
  499. Mapping genes for complex traits: OBESITY, diabetes, hypertension, and DYSLIPIDEMIA on the Pacific island of Kosrae
  500. IMPACT OF OBESITY AND FAT DISTRIBUTION IN METABOLIC DYSLIPIDEMIA OF THE ELDERLY IN SPAIN: A POPULATION-BASED STUDY: PP. 34.357
  501. Brain-specific disruption of the insulin receptor gene in mice results in OBESITY, hyperinsulinemia and DYSLIPIDEMIA
  502. Research article Central OBESITY and atherogenic DYSLIPIDEMIA in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese …
  503. DYSLIPIDEMIA Induces Independent Mechanisms Regulating Skeletal Muscle Protein Metabolism and Glucose Balance in Human OBESITY
  504. Cardiac Rehabilitation in Patient with Inferior STEMI, CAD 3VD Post Stent to RCA, DM Type II, DYSLIPIDEMIA, and OBESITY Grade I
  505. OBESITY, DYSLIPIDEMIA, Diabetes, and Vitamin D Levels
  506. EFFECT OF DYSLIPIDEMIA AND AMOUNT OF VISCERAL FAT ON THE COURSE OF BRONCHIAL ASTHMA AGAINST THE BACKGROUND OF …
  507. ABDOMINAL OBESITY, DYSLIPIDEMIA, INSULIN RESISTANCE, TYPE 2 DIABETES AND ATHEROSCLEROSIS: WHO IS THE RIGHT PATIENT TO BE …
  508. Relationship Between DYSLIPIDEMIA and OBESITY in Children
  509. Two single nucleotide polymorphisms (SNPs) in thyroid hormone receptor-alpha may affect the risk of OBESITY and DYSLIPIDEMIA
  510. Familial Isolated Growth Hormone Deficiency Is Associated with Hypertension, Central OBESITY and DYSLIPIDEMIA But not the Classical Syndrome X
  511. Alcohol intake is less important as predictive factors for development of fatty liver disease compared to OBESITY, impairment of glucose metabolism and DYSLIPIDEMIA …
  512. Crown-like structures and adipocyte size in fat tissue adjacent to breast tumor reflect parameters of OBESITY, DYSLIPIDEMIA and serum high-sensitivity C-reactive protein
  513. Postprandial DYSLIPIDEMIA, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with OBESITY-Supplemental Files
  514. … ARTICLE by a Recently Elected Academy Member: Linkage analysis of quantitative traits for OBESITY, diabetes, hypertension, and DYSLIPIDEMIA on the island …
  515. PW217 The epidemiology of DYSLIPIDEMIA, OBESITY and other cardiovascular risk factors in the general adult population in Senegal
  516. Low Copy Number of the Salivary Amylase Gene (AMY1) Is Associated with OBESITY, DYSLIPIDEMIA, and Chronic Low-Grade Inflammation but Not Insulin Sensitivity …
  517. DYSLIPIDEMIA in patients with type 2 diabetes according to the degree and type of OBESITY
  518. PREVALENCE AND STRUCTURE OF DYSLIPIDEMIA IN CHILDREN AND ADOLESCENTS WITH OBESITY AND OVERWEIGHT
  519. Hyperinsulinemia leads the elevation of plasma aldosterone concentration independently with OBESITY, DYSLIPIDEMIA, and insulin resistance in patients with type 2 …
  520. Role of Vyoshadi guggulu in Medorog (OBESITY) associated with DYSLIPIDEMIA: a case study.
  521. FXR activation normalizes DYSLIPIDEMIA and alleviates OBESITY in western-type diet–fed APOE* 3-Leiden. CETP transgenic mice
  522. CORTISOL PLASMA LEVEL: THE LINK TO POSTPRANDIAL HYPERINSULINEMIA, OBESITY, DYSLIPIDEMIA AND GENDER IN PATIENTS WITH ARTERIAL …
  523. Dietary 23–Hydroxy Ursolic Acid Protects Against Atherosclerosis And OBESITY By Preventing DYSLIPIDEMIA-Induced Monocyte Priming And Dysfunction
  524. Chronic Infusion of Norepinephrine Into the Ventromedial Hypothalamus Induces DYSLIPIDEMIA and OBESITY in Rats
  525. CORRELATION OF DIABETES MELLITUS AND DYSLIPIDEMIA WITH OBESITY IN INFERTILE FEMALES: A CROSS SECTIONAL STUDY
  526. Association Between OBESITY, DYSLIPIDEMIA and Apoliporprotein E Polymorphism
  527. ASSOCIATION OF DYSLIPIDEMIA AND OBESITY AFTER MENOPAUSE
  528. 11 The Evaluation of DYSLIPIDEMIA and OBESITY
  529. Confirmation of a Major QTL, Dmo1, Linked to OBESITY, DYSLIPIDEMIA and Hyperglycemia in the Otsuka Long Evans Tokushima Fatty (OLETF) Rat
  530. Protective effects of a new AMPK activator, LNP599, in a marmoset model of diet-induced OBESITY and DYSLIPIDEMIA
  531. Statistical analysis of overweight/OBESITY and DYSLIPIDEMIA in 457 students in Guangzhou.
  532. DYSLIPIDEMIA and abdominal OBESITY: therapeutic approaches (Part II)
  533. Corrigendum: Ameliorating effects of Sporidiobolus pararoseus extract on DYSLIPIDEMIA in mice with high fat diet induced OBESITY
  534. Central OBESITY, hepatic lipase activity and DYSLIPIDEMIA in type 1 diabetes
  535. DYSLIPIDEMIA+obesity&ots=0fwHWzzdBW&sig=iHkOvss4vyNzaJV-DU5K2CK1Ujs”>OBESITY increases risk for or exists concomitantly with nearly every prevent-able chronic condition, from type 2 diabetes to DYSLIPIDEMIA, to poor mental health. Its …
  536. Hypertension, OBESITY measures and DYSLIPIDEMIA: a case-control study.
  537. OBESITY and DYSLIPIDEMIA in patients with psoriasis: a case-control study.
  538. Association between OBESITY and DYSLIPIDEMIA with the risk of mild cognitive decline and dementia: a the risk of mild cognitive decline and dementia: a systematic …
  539. Physical exercises and nutritional guidance versus simvastatin on children with OBESITY-related DYSLIPIDEMIA
  540. Overweight, OBESITY and DYSLIPIDEMIA in a Mexican University Population
  541. Relationship between DYSLIPIDEMIA and OBESITY caused by meat-eating diet among people aged 18 and over in plateau areas of Qinghai
  542. … : OBESITY and Type 2 Diabetes in Patients with NAFLD Are Independently Associated with the Risk of Liver Fibrosis, Insulin Resistance, and Atherogenic DYSLIPIDEMIA
  543. Analysis on prevalence of overweight and OBESITY and their relation with diabetes, hypertension, DYSLIPIDEMIA among adults in Pinghu City
  544. Is central OBESITY, hyperinsulinemia and DYSLIPIDEMIA associated with high-grade prostate cancer? A descriptive cross-sectional study.
  545. Management of OBESITY, hypertension, DYSLIPIDEMIA and diabetes through diet therapy
  546. Correlation among fatty liver, OBESITY and DYSLIPIDEMIA in staff of government division.
  547. Body mass index is better than other anthropometric indices for identifying DYSLIPIDEMIA in Chinese children with OBESITY.
  548. Effects of dietary strawberries on inflammatory biomarkers in participants with abdominal OBESITY and DYSLIPIDEMIA
  549. Associations of OBESITY and DYSLIPIDEMIA with intake of sodium, fat, and sugar among Koreans: a qualitative systematic review.
  550. Lactobacillus fermentum CQPC07 Attenuates OBESITY, Inflammation and DYSLIPIDEMIA by Modulating the Antioxidant Capacity and Lipid Metabolism in High-fat Diet …
  551. CANNABINOID 1 RECEPTOR BLOCKADE DIMINISHES OBESITY AND DYSLIPIDEMIA VIA PERIPHERAL ACTIVATION OF BROWN ADIPOSE TISSUE
  552. Association of OBESITY and insulin resistance with DYSLIPIDEMIA in Indian women with polycystic ovarian syndrome.
  553. Hypoadiponectinemia is associated with OBESITY, and DYSLIPIDEMIA in Korean patients with type 2 diabetes mellitus (DM)
  554. Effect of OBESITY and Associated Disorders like Diabetes, DYSLIPIDEMIA & Hypertension on Levels of Serum Complement Component C3 in Indian Ethnic Population
  555. Association of anthropometric indices of OBESITY with diabetes, hypertension and DYSLIPIDEMIA, a study conducted at Teaching Hospital of Sukkur, Sindh, Pakistan
  556. Fish Oil and Cyclooxygenase Inhibitors: a Novel Strategy to Manage OBESITY-linked DYSLIPIDEMIA
  557. A genome-wide search for gene-by-OBESITY interaction loci of DYSLIPIDEMIA in Koreans shows diverse genetic risk alleles.
  558. SYMPOSIUMS: WHETHER GENE-FAT INTAKE INTERACTIONS ARE DIFFERENTIALLY DRIVING THE RISK OF OBESITY AND DYSLIPIDEMIA
  559. Monocyte DPP4 expression in human atherosclerosis is associated with OBESITY and DYSLIPIDEMIA.
  560. 13 OBESITY and DYSLIPIDEMIA: Importance of Body Fat Distribution
  561. Central OBESITY as a reliable predictor for hypertension and DYSLIPIDEMIA: Tehran lipid glucose study
  562. Functional foods against metabolic syndrome (OBESITY, diabetes, hypertension and DYSLIPIDEMIA) and cardiovasular disease.
  563. Prevention of aqueous extract from chrysanthemum morifolium of Chuju against high-fat diet induced OBESITY and DYSLIPIDEMIA.
  564. HEPATIC STEATOSIS IS ASSOCIATED WITH ATHEROGENIC DYSLIPIDEMIA INDEPENDENT OF OBESITY, COMPONENTS OF THE METABOLIC SYNDROME …
  565. Genetic variants of resistin and its plasma levels: association with OBESITY and DYSLIPIDEMIA related to Type 2 Diabetes susceptibility.
  566. Self-reported snoring is associated with DYSLIPIDEMIA, high total cholesterol, and high low-density lipoprotein cholesterol in OBESITY: a cross-sectional study from a rural …
  567. Insulin resistance, atherogenic DYSLIPIDEMIA and other atherogenic factors in simple OBESITY and OBESITY with Acanthosis nigricans (an) in childhood
  568. Effect of ShanZha, a Chinese herbal product, on OBESITY and DYSLIPIDEMIA in hamsters receiving high-fat diet.
  569. Impact of a 1-year lifestyle modification program on cholesterol efflux capacities in men with abdominal OBESITY and 2 DYSLIPIDEMIA 3
  570. Low dose organochlorine pesticides and polychlorinated biphenyls predict OBESITY, DYSLIPIDEMIA, and insulin resistance among people free of diabetes.
  571. Plasma Active Ghrelin Level in Patients with Type 2 Diabetes Mellitus and its Interrelationship with Insulin resistance, Hypertension, DYSLIPIDEMIA and OBESITY
  572. Association between Promoter Polymorphism (rs2243115,− 570 T/G) of Interleukin 12A and DYSLIPIDEMIA and OBESITY in Korean Population
  573. … by the French National Nutritional and Health Program (PNNS) in its Health Survey (ENNS 2006): prevalence of OBESITY, high blood-pressure and DYSLIPIDEMIA
  574. Perilla leaf extract ameliorates OBESITY and DYSLIPIDEMIA induced by high-fat diet.
  575. Central OBESITY and atherogenic DYSLIPIDEMIA in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
  576. Ameliorating effects of Sporidiobolus pararoseus extract on DYSLIPIDEMIA in mice with high fat diet induced OBESITY.
  577. Whole barley prevents OBESITY and DYSLIPIDEMIA without the involvement of the gut microbiota in germ free C57BL/6J obese mice.
  578. Studies on the unique properties of resistant starch and chito-oligosaccharide complexes for reducing high-fat diet-induced OBESITY and DYSLIPIDEMIA in rats.
  579. Joint effects of hypertension, smoking, DYSLIPIDEMIA and OBESITY and angiotensin-converting enzyme DD genotype on albuminuria in Taiwanese patients with type 2 …
  580. Antrodia cinnamomea prevents OBESITY, DYSLIPIDEMIA, and the derived fatty liver via regulating AMPK and SREBP signaling.
  581. Cholesterol exacerbates diet-induced OBESITY, insulin resistance, and DYSLIPIDEMIA, via induction of hepatic lipogenesis and steatosis.
  582. … to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With DYSLIPIDEMIA, Insulin Resistance, OBESITY, and Chronic Inflammation …
  583. Serum retinol-binding protein 4 correlates with OBESITY, insulin resistance, and DYSLIPIDEMIA in HIV-infected subjects receiving highly active antiretroviral therapy.
  584. Cannabinoid 1 Receptor Blockade Diminishes OBESITY and DYSLIPIDEMIA via Peripheral Activation of Brown Adipose Tissue
  585. Corrigendum to” Dietary protein dilution limits DYSLIPIDEMIA in OBESITY through FGF21-driven fatty acid clearance”[The Journal of Nutritional Biochemistry 57 (2018) …
  586. Dietary 23-hydroxy ursolic acid protects against atherosclerosis and OBESITY by preventing DYSLIPIDEMIA-induced monocyte priming and dysfunction.
  587. Multivariate analysis of genomics data to identify potential pleiotropic genes for type 2 diabetes, OBESITY and DYSLIPIDEMIA using meta-CCA and gene-based approach.
  588. 1890-P: Lipocalin-Type Prostaglandin D2 Synthase Deficient Mice Develop DYSLIPIDEMIA Resulting in Nonalcoholic Fatty Liver Disease Independent of OBESITY
Related Posts

Xenoestrogen

Addiction & Dopamine

(Ampk) (Activator | Activators | Activation)

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping